You are here

  • Home
  • Archive
  • Volume 15, Issue 8
  • Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumab

Article metrics

Article menu
Download PDFPDF
Case Reports: Rare disease
Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumab

 

Online download statistics by month:

Online download statistics by month: August 2022 to April 2024

AbstractFullPdf
Aug 202219244
Sep 202212215619
Oct 2022612162
Nov 202217440
Dec 202223286
Jan 2023226189
Feb 202320066
Mar 202313262
Apr 202311841
May 20236302
Jun 20238022
Jul 20237411
Aug 20236122
Sep 20235321
Oct 20235820
Nov 20235955
Dec 20235612
Jan 20245220
Feb 20245133
Mar 20249134
Apr 20245411
Total385914672